Mckinley Capital Management LLC Delaware acquired a new position in shares of CIGNA Co. (NYSE:CI) in the fourth quarter, Holdings Channel reports. The institutional investor acquired 52,600 shares of the health services provider’s stock, valued at approximately $10,683,000.

Other institutional investors and hedge funds also recently modified their holdings of the company. Saratoga Research & Investment Management bought a new stake in CIGNA during the 3rd quarter worth approximately $112,000. Stuart Chaussee & Associates Inc. bought a new stake in CIGNA during the 4th quarter worth approximately $122,000. Horan Capital Advisors LLC. bought a new stake in CIGNA during the 3rd quarter worth approximately $123,000. Cerebellum GP LLC bought a new stake in CIGNA during the 4th quarter worth approximately $127,000. Finally, Grove Bank & Trust increased its holdings in CIGNA by 171.9% during the 3rd quarter. Grove Bank & Trust now owns 976 shares of the health services provider’s stock worth $182,000 after purchasing an additional 617 shares in the last quarter. 88.60% of the stock is owned by hedge funds and other institutional investors.

CI has been the subject of several recent analyst reports. Jefferies Group upped their target price on CIGNA from $221.00 to $231.00 and gave the company a “buy” rating in a report on Friday, November 3rd. Zacks Investment Research raised CIGNA from a “hold” rating to a “buy” rating and set a $231.00 target price for the company in a report on Friday, December 22nd. Citigroup upped their target price on CIGNA from $198.00 to $231.00 and gave the company a “buy” rating in a report on Friday, November 3rd. ValuEngine raised CIGNA from a “hold” rating to a “buy” rating in a report on Sunday, December 31st. Finally, BMO Capital Markets initiated coverage on CIGNA in a report on Monday, October 16th. They issued a “market perform” rating and a $210.00 target price for the company. Three research analysts have rated the stock with a hold rating, fifteen have assigned a buy rating and one has given a strong buy rating to the stock. The company has an average rating of “Buy” and a consensus price target of $210.12.

In related news, insider Christopher J. Hocevar sold 8,387 shares of the company’s stock in a transaction that occurred on Monday, November 27th. The stock was sold at an average price of $200.32, for a total value of $1,680,083.84. Following the transaction, the insider now owns 12,363 shares in the company, valued at $2,476,556.16. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, EVP Alan Muney sold 15,345 shares of the company’s stock in a transaction that occurred on Monday, November 27th. The shares were sold at an average price of $200.80, for a total value of $3,081,276.00. Following the completion of the transaction, the executive vice president now owns 28,457 shares in the company, valued at approximately $5,714,165.60. The disclosure for this sale can be found here. In the last quarter, insiders sold 64,663 shares of company stock worth $13,329,903. 1.30% of the stock is owned by company insiders.

CIGNA Co. (NYSE CI) opened at $193.56 on Tuesday. CIGNA Co. has a 12 month low of $141.93 and a 12 month high of $227.13. The company has a quick ratio of 0.39, a current ratio of 0.37 and a debt-to-equity ratio of 0.38. The company has a market capitalization of $47,273.49, a P/E ratio of 22.17, a P/E/G ratio of 1.16 and a beta of 0.45.

CIGNA (NYSE:CI) last posted its quarterly earnings data on Thursday, February 1st. The health services provider reported $1.94 EPS for the quarter, beating the consensus estimate of $1.87 by $0.07. CIGNA had a return on equity of 18.84% and a net margin of 5.38%. The business had revenue of $10.53 billion for the quarter, compared to the consensus estimate of $10.28 billion. During the same quarter in the prior year, the business earned $1.87 earnings per share. CIGNA’s revenue for the quarter was up 5.9% on a year-over-year basis. equities analysts expect that CIGNA Co. will post 12.9 EPS for the current year.

ILLEGAL ACTIVITY NOTICE: “Mckinley Capital Management LLC Delaware Takes $10.68 Million Position in CIGNA Co. (CI)” was published by Watch List News and is the property of of Watch List News. If you are viewing this story on another domain, it was stolen and republished in violation of United States and international copyright law. The original version of this story can be accessed at https://www.watchlistnews.com/mckinley-capital-management-llc-delaware-takes-10-68-million-position-in-cigna-co-ci/1863778.html.

About CIGNA

Cigna Corporation (Cigna), together with its subsidiaries, is a health services company. The Company offers medical, dental, disability, life and accident insurance and related products and services. The Company’s segments include Global Health Care, Global Supplemental Benefits, Group Disability and Life, and Other Operations and Corporate.

Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CIGNA Co. (NYSE:CI).

Institutional Ownership by Quarter for CIGNA (NYSE:CI)

Receive News & Ratings for CIGNA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CIGNA and related companies with MarketBeat.com's FREE daily email newsletter.